Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Johnson & Johnson | 32 | 1 | 2 | 0 | €137.30 | €196.74 | 43.289% |
| AbbVie Inc. | 20 | 1 | 3 | 1 | €150.82 | €174.43 | 15.657% |
| Henry Schein Inc. | 11 | 1 | 0 | 0 | €68.12 | €79.30 | 16.413% |
| AnaptysBio Inc | 7 | 1 | 2 | 0 | €19.90 | €45.21 | 127.186% |
| Gilead Sciences Inc | 11 | 1 | 4 | 0 | €61.51 | €88.73 | 44.253% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €457.25 | €543.72 | 18.911% |
| Bruker Corp. | 7 | 1 | 0 | 1 | €76.22 | €85.68 | 12.417% |
| Insmed Inc. | 13 | 1 | 3 | 1 | €23.20 | €44.01 | 89.684% |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | €121.40 | €124.93 | 2.907% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €41.20 | €82.93 | 101.289% |
| Teva Pharmaceutical Industries Ltd ADR | 11 | 0 | 0 | 0 | €13.05 | €13.68 | 4.828% |
| Boston Scientific | 46 | 0 | 13 | 0 | €68.00 | €72.96 | 7.289% |
| Viracta Therapeutics Inc. | 2 | 0 | 2 | 0 | €0.81 | - | - |
| Icon plc | 18 | 0 | 6 | 0 | €283.60 | €319.67 | 12.718% |
| Thermo Fisher Scientific Inc. | 26 | 0 | 5 | 0 | €539.30 | €566.65 | 5.071% |
| ImmunityBio Inc. | 3 | 0 | 2 | 0 | €8.50 | €10.00 | 17.675% |
| Merit Medical Systems | 13 | 0 | 2 | 0 | €69.50 | €86.72 | 24.772% |
| GSK plc ADR | 4 | 0 | 0 | 0 | €38.20 | €35.00 | -8.377% |
| Vanda Pharmaceuticals | 4 | 0 | 2 | 0 | €4.54 | €5.00 | 10.132% |
| Vericel Corp. | 1 | 0 | 0 | 0 | €43.20 | - | - |
| Amedisys Inc. | 13 | 0 | 1 | 0 | €84.00 | €92.26 | 9.833% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €5.97 | €19.86 | 233.024% |
| Dentsply Sirona Inc. | 10 | 0 | 0 | 0 | €28.64 | €38.55 | 34.608% |
| Virbac S.A. | 1 | 0 | 0 | 0 | €344.50 | €310.00 | -10.015% |